Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanwal Raghav

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Cancer Medicine|December 31, 2015
Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstructionJay Chouhan, Rohan Gupta, Joe Ensor, et al.
JAMA Oncology|November 2, 2018
Assessment of Reported Trial Characteristics, Rate of Publication, and Inclusion of Mandatory Biopsies of Research Biopsies in Clinical Trials in OncologyChristine M Parseghian, Alda L Tam, James Yao, et al.
BMC Cancer|October 19, 2019
Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portraitRyan W Huey, Shalini Makawita, Lianchun Xiao, et al.
Plos One|May 13, 2016
Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival OutcomesKanwal Raghav, Hemendra Mhadgut, Jennifer L McQuade, et al.
The Oncologist|December 21, 2017
Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of VaterPat Gulhati, Kanwal Raghav, Rachna Shroff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2017
Underreporting of Research Biopsies from Clinical Trials in OncologyChristine M Parseghian, Kanwal Raghav, Robert A Wolff, et al.
JNCI Cancer Spectrum|July 25, 2020
Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical CompaniesJoseph M Unger, Dawn L Hershman, Raymond U Osarogiagbon, et al.
Current Oncology (Toronto, Ont.)|January 27, 2021
Virtual Oncology Appointments during the Initial Wave of the COVID-19 Pandemic: An International Survey of Patient PerspectivesJonathan M Loree, Hallie Dau, Nevena Rebić, et al.
Cancer Treatment Reviews|May 7, 2018
Untying the gordion knot of targeting MET in cancerKanwal Raghav, Ann Marie Bailey, Jonathan M Loree, et al.
Annals of Surgical Oncology|September 24, 2016
Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-upKeith Fournier, Safia Rafeeq, Melissa Taggart, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Cancer Medicine|December 31, 2015
Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstructionJay Chouhan, Rohan Gupta, Joe Ensor, et al.
JAMA Oncology|November 2, 2018
Assessment of Reported Trial Characteristics, Rate of Publication, and Inclusion of Mandatory Biopsies of Research Biopsies in Clinical Trials in OncologyChristine M Parseghian, Alda L Tam, James Yao, et al.
BMC Cancer|October 19, 2019
Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portraitRyan W Huey, Shalini Makawita, Lianchun Xiao, et al.
Plos One|May 13, 2016
Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival OutcomesKanwal Raghav, Hemendra Mhadgut, Jennifer L McQuade, et al.
The Oncologist|December 21, 2017
Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of VaterPat Gulhati, Kanwal Raghav, Rachna Shroff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2017
Underreporting of Research Biopsies from Clinical Trials in OncologyChristine M Parseghian, Kanwal Raghav, Robert A Wolff, et al.
JNCI Cancer Spectrum|July 25, 2020
Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical CompaniesJoseph M Unger, Dawn L Hershman, Raymond U Osarogiagbon, et al.
Current Oncology (Toronto, Ont.)|January 27, 2021
Virtual Oncology Appointments during the Initial Wave of the COVID-19 Pandemic: An International Survey of Patient PerspectivesJonathan M Loree, Hallie Dau, Nevena Rebić, et al.
Cancer Treatment Reviews|May 7, 2018
Untying the gordion knot of targeting MET in cancerKanwal Raghav, Ann Marie Bailey, Jonathan M Loree, et al.
Annals of Surgical Oncology|September 24, 2016
Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-upKeith Fournier, Safia Rafeeq, Melissa Taggart, et al.
Pageof 11